Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI
Clinical trial NCT02298660 · COMPLETED
Trial details
- NCT number
- NCT02298660
- Sponsor
- Rick Hansen Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2017-10-17
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.